Clinical Trial Update: Triamcinolone Ketorolac (TriKe) Knee Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating that recruitment is ongoing for TriKe (Triamcinolone Ketorolac) in knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• TriKe (Triamcinolone Ketorolac) (Triamcinolone ketorolac)

Snippet

Sponsor: United Health Services Hospitals, Inc. | Conditions: Osteoarthritis, Knee | Phase 4 | Status: RECRUITING